Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
MT-II is a cyclic heptapeptide broadly activating MC1R, MC3R, and MC4R , simultaneously producing melanogenesis alongside central pro-sexual, pro-erectile, and anorectic effects through hypothalamic MC3R/MC4R activation, Cyclisation of the -MSH pharmacophore core is the primary structural determinant of this receptor subtype selectivity shift
Medically-guided care trusted by over 150,000 patients, with a 4.9 star rating and 1 million+ therapies provided
doi: 10.3389/fphys.2022.954948 Received 27 May 2022 Accepted 28 July 2022 Published 25 August 2022 Volume 13 - 2022 Edited by Robert Roghair, The University of Iowa, United States Reviewed by Jeffrey Segar, Medical College of Wisconsin, United States Michael Satterfield, Texas A&M University, United States Updates Copyright 2022 Stremming, White, Donthi, Batt, Hetrick, Chang, Wesolowski, Seefeldt, McCurdy, Rozance and Brown
You may change the day of the week as long as your last dose was given 3 or more days before
Use stool softeners or osmotic laxatives when needed, after checking with your clinician
Oocyte Maturation Rate: It is generally related to nuclear maturity, being defined as the proportion of oocytes at MII stage (18)
US$ 24.04
US$ 22.56
US$ 21.71
US$ 22.99
US$ 23.43
US$ 20.39
US$ 28.42
